A Narrative Review of Financial Burden, Distress and Toxicity of Inflammatory Bowel Diseases in the United States.
Olivia Kahn-BoeselSandhya CautaNneka N UfereAshwin N AnanthakrishnanBharati Kochar MsPublished in: The American journal of gastroenterology (2023)
Financial distress is prevalent among patients with IBD; financial toxicity is not well characterized. Definitions and measures varied widely. Better quantification of patient-level costs and associated impacts is needed to determine avenues for intervention.